Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-30,025
Closed -$376K – 1458
2024
Q1
$376K Buy
+30,025
New +$388K 0.02% 461
2020
Q3
– Sell
-23,412
Closed -$358K – 2441
2020
Q2
$358K Buy
+23,412
New +$348K 0.01% 1393
2020
Q1
– Sell
-14,593
Closed -$351K – 2032
2019
Q4
$351K Buy
+14,593
New +$333K 0.01% 1635
2019
Q3
– Sell
-13,161
Closed -$291K – 2275
2019
Q2
$291K Buy
+13,161
New +$305K ﹤0.01% 1317
2018
Q3
– Sell
-11,373
Closed -$307K – 1927
2018
Q2
$307K Buy
+11,373
New +$301K 0.01% 1266
2017
Q4
– Sell
-31,120
Closed -$699K – 2275
2017
Q3
$699K Buy
31,120
+3,761
+14% +$85K 0.01% 1351
2017
Q2
$725K Sell
27,359
-9,176
-25% -$245K 0.01% 1360
2017
Q1
$999K Buy
36,535
+17,558
+93% +$448K 0.01% 1242
2016
Q4
$468K Buy
+18,977
New +$400K ﹤0.01% 1539
2016
Q2
– Sell
-10,598
Closed -$278K – 2334
2016
Q1
$278K Buy
10,598
+746
+8% +$17.3K ﹤0.01% 1560
2015
Q4
$254K Sell
9,852
-3,246
-25% -$87.6K 0.01% 1424
2015
Q3
$295K Buy
13,098
+98
+0.8% +$2.51K 0.01% 1288
2015
Q2
$389K Buy
+13,000
New +$366K 0.01% 1203

Other funds holding TBI

Paloma Partners's TBI Position: Q2 2024 in Review

Paloma Partners sold out of Trueblue (TBI) in Q2 2024, closing a stake of 30,025 shares — an estimated $376K sold.

Paloma Partners first reported a position in TBI in Q2 2015 and held it in 13 quarters. The position peaked at $999K in Q1 2017. 121 funds tracked by Wall St. Rank hold TBI as of Q2 2024.

  • Paloma Partners reported no remaining Trueblue position as of Q2 2024 after selling out during the quarter.
  • Paloma Partners sold 30,025 Trueblue shares in Q2 2024, an estimated $376K.
  • Paloma Partners first reported a position in Trueblue in Q2 2015 and held it in 13 quarters.
  • Paloma Partners's Trueblue position peaked at $999K in Q1 2017.
  • 121 funds tracked by Wall St. Rank held Trueblue as of Q2 2024.

Based on Paloma Partners's 13F filing for Q2 2024, filed 14 Aug 2024.